Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

IP-10 available for licensing from NIH

Jan. 16, 1998

Japanese marketing agreement announced for Bio-Technology General's hGH

Jan. 15, 1998

Abbott in-licenses lipid-lowering drug from Fournier

Jan. 14, 1998

IC-351 advances to phase II for MED

Jan. 14, 1998

Eisai in-licenses antiobesity drug for Japanese market

Jan. 14, 1998

Neupogen approved for use in AIDS patients

Jan. 13, 1998

GeneMedicine will not conduct scheduled clinical trial of IGF-I Gene Medicine

Jan. 13, 1998

GH release-stimulating compounds reported by Novo Nordisk

Jan. 13, 1998

Sumitomo and Genentech collaborate on two GH products

Jan. 13, 1998

New hematopoietic growth factor family presented

Jan. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...